Syncope and autonomic cardiovascular dysfunction in Parkinson disease;Zaburzenia unerwienia autonomicznego układu sercowo-naczyniowegoa występowanie omdleń u osób z chorobą Parkinsona

Neurologia i Neurochirurgia Polska

Volumn 45, Issue 4, 2011, Pages 335-341

  Leńska Mieciek, Marta ^a   Derecka Charzyńska, Ingeborga ^b   Fiszer, Urszula ^a   Królicki, Leszek ^b   Kułakowski, Piotr ^c  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Centrum Medyczne Kszta cenia Podyplomowego   (Poland)

Author keywords

Myocardial scintigraphy; Parkinson disease; Syncope

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; MALE; MYOCARDIAL PERFUSION IMAGING; PARKINSON DISEASE; PRESYNCOPE; SYMPTOM; SYNCOPE; SYSTOLIC BLOOD PRESSURE;

EID: 80054889589     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60104-3     Document Type: Article

References (23)

1. Braak H., Ghebremedhin E., Rüb U., et al. Stages in development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134.
2. Fujishiro H., Frigerio R., Burnett M., et al. Cardiac sympathetic de nervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord 2008; 23: 1085-1092.
3. Kline R.C., Swanson D.P., Wieland D.M., et al. Myocardial imaging in man with I-123-meta-iodobenzylguanidine. J Nucl Med 1981; 22: 129-132.
4. Rascol O., Schelosky L. 123I-metaiodobenzylguanidine scin - tigraphy in Parkinson's disease and related disorders. Mov Disord 2009; 24: S732-S741.
5. Braune S., Reinhardt M., Bathmann J., et al. Impaired cardiac uptake of meta-[123I]iodobenzyloguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand 1998; 97: 307-314.
6. Yoshita M., Hayashi M., Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease. Nucl Med Commun 1998; 19: 137-142.
7. Orimo S., Ozawa E., Nakade S., et al. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 189-194.
8. Nagayama H., Hamamoto M., Ueda M., et al. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2005; 76: 249-251.
9. Campos V., Rebollo A.C., Jimenez-Hoyuela J.M., et al. Early alterations of adrenergic cardiac function in Parkinson's disease. Neurologia 2004; 19: 53-58.
10. Courbon F., Brefel-Courbon C., Thalamas C., et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 2003; 18: 890-897.
11. Spiegel J., Mollers M.O., Jost W.H., et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 2005; 20: 552-561.
12. Shibata M., Morita Y., Shimizu T., et al. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci 2009; 276: 79-83.
13. Goldstein D.S., Holmes C.S., Dendi R., et al. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 2002; 58: 1247-1255.
14. Czarkowska H., Tutaj M., Rudziñska M., et al. Wysta{ogonek}pienie upad ków w chorobie Parkinsona wia{ogonek}że sie{ogonek} z pogorszeniem regulacji czynności serca w czasie pionizacji. Neurol Neurochir Pol 2010; 44: 339-349.
15. Chung E.J., Lee W.Y., Yoon W.T., et al. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Mov Disord 2009; 24: 1650-1655.
16. Oertel W.H., Quinn N.P. Parkinsonism. In: Brandt T., Cap - lan L.R. [eds.]. Neurological disorders: course and treatment. Academic Press, San Diego 1996, pp. 715-772.
17. Brignole M., Alboni P., Benditt D.G., et al. Guidelines on mana - gement (diagnosis and treatment) of syncope-update 2004. Europace 2004; 6: 467-537.
18. Carrio I. Cardiac neurotransmission imaging. J Nucl Med 2001; 42: 1062-1076.
19. Ziemssen T., Reichmann H. Cardiovascular autonomic dysfunction in Parkinson's disease. J Neurol Sci 2010; 289: 74-80.
20. Merlet P., Piot O., Dubois-Rande J.L., et al. Clinical use of metaiodobenzylguanidine imaging in cardiology. Q J Nucl Med 1995; 39: 29-39.
21. Deguchi K., Sasaki I., TsukaguchiM., et al. Abnormalities of ratecorrected QT intervals in Parkinson's disease - a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 2002; 199: 31-37.
22. Agostini D., Verberne H.J., Burchert W., et al. I-123-MIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective Euro - pean multicenter study. Eur J Nucl Med Mol Imaging 2008; 35: 535-546.
23. Post K.K., Singer C., Papapetropoulos S., et al. Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques. Parkinsonism Relat Disord 2008; 14: 524-531.